{"id":22759,"date":"2025-10-22T12:19:05","date_gmt":"2025-10-22T12:19:05","guid":{"rendered":"https:\/\/itbusinesstoday.com\/?p=22759"},"modified":"2025-10-22T12:19:05","modified_gmt":"2025-10-22T12:19:05","slug":"innovent-biologics-teams-with-takeda-on-global-io-therapies","status":"publish","type":"post","link":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/innovent-biologics-teams-with-takeda-on-global-io-therapies\/","title":{"rendered":"\u30a4\u30ce\u30d9\u30f3\u30c8\u30fb\u30d0\u30a4\u30aa\u30ed\u30b8\u30af\u30b9\u304c\u6b66\u7530\u85ac\u54c1\u3068\u30b0\u30ed\u30fc\u30d0\u30ebIO\u6cbb\u7642\u85ac\u3067\u63d0\u643a"},"content":{"rendered":"<p>Innovent Biologics\u793e\u3068\u6b66\u7530\u85ac\u54c1\u304c\u63d0\u643a\u3057\u307e\u3057\u305f\u306e\u3067\u304a\u77e5\u3089\u305b\u3057\u307e\u3059\u3002\u6b66\u7530\u85ac\u54c1\u3068\u30a4\u30ce\u30d9\u30f3\u30c8\u30d0\u30a4\u30aa\u30ed\u30b8\u30af\u30b9\u306f\u3001\u3053\u306e\u305f\u3073\u3001\u6b66\u7530\u85ac\u54c1\u3068\u30a4\u30ce\u30d9\u30f3\u30c8\u30d0\u30a4\u30aa\u30ed\u30b8\u30af\u30b9\u304c\u63d0\u643a\u3059\u308b\u3053\u3068\u306b\u306a\u308a\u307e\u3057\u305f\u306e\u3067\u304a\u77e5\u3089\u305b\u3057\u307e\u3059\u3002\u3053\u306e\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u306f\u3001\u753b\u671f\u7684\u306a\u304c\u3093\u6cbb\u7642\u3092\u4e16\u754c\u4e2d\u306e\u60a3\u8005\u3055\u3093\u306b\u63d0\u4f9b\u3059\u308b\u3053\u3068\u3092\u76ee\u7684\u3068\u3057\u3066\u3044\u307e\u3059\u3002\u4e21\u793e\u306e\u6280\u8853\u3092\u7d50\u96c6\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u672c\u63d0\u643a\u306f\u3001\u30a4\u30ce\u30d9\u30f3\u30c8\u306eIO+ADC\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u304b\u30893\u3064\u306e\u4e3b\u8981\u306a\u6cbb\u9a13\u85ac\u306b\u7126\u70b9\u3092\u5f53\u3066\u305f\u3082\u306e\u3067\u3059\u3002IBI363\u306f\u3001PD-1\u3068IL-2\u03b1\u3092\u6a19\u7684\u3068\u3059\u308b\u30d5\u30a1\u30fc\u30b9\u30c8\u30fb\u30a4\u30f3\u30fb\u30af\u30e9\u30b9\u306e\u4e8c\u91cd\u7279\u7570\u6027\u6297\u4f53\u878d\u5408\u30bf\u30f3\u30d1\u30af\u8cea\u3067\u3059\u3002\u5f37\u529b\u306a\u6297\u816b\u760d\u52b9\u679c\u3092\u793a\u3057\u307e\u3059\u3002\u514d\u75ab\u816b\u760d\u5b66\u306e\u65b0\u3057\u3044\u6cbb\u7642\u6cd5\u3068\u3057\u3066\u671f\u5f85\u3055\u308c\u3066\u3044\u307e\u3059\u3002IBI363\u306f\u73fe\u5728\u30b0\u30ed\u30fc\u30d0\u30eb\u3067\u30d5\u30a7\u30fc\u30ba3\u958b\u767a\u4e2d\u3067\u3059\u3002\u5bfe\u8c61\u306f\u4e8c\u6b21\u6cbb\u7642\u306e\u6241\u5e73\u4e0a\u76ae\u975e\u5c0f\u7d30\u80de\u80ba\u304c\u3093\uff08sqNSCLC\uff09\u3067\u3059\u3002\u672c\u85ac\u306f\u3001\u4e2d\u56fd\u306eNMPA\u3088\u308a\u30d6\u30ec\u30fc\u30af\u30b9\u30eb\u30fc\u6307\u5b9a\u3001\u7c73\u56fdFDA\u3088\u308a\u30d5\u30a1\u30b9\u30c8\u30fb\u30c8\u30e9\u30c3\u30af\u6307\u5b9a\u3092\u53d6\u5f97\u3057\u3066\u3044\u307e\u3059\u3002\u30a4\u30ce\u30d9\u30f3\u30c8\u793e\u3068\u6b66\u7530\u85ac\u54c1\u306f\u3001IBI363\u306e\u30b0\u30ed\u30fc\u30d0\u30eb\u958b\u767a\u3092\u5171\u540c\u3067\u884c\u3044\u307e\u3059\u3002\u6b66\u7530\u85ac\u54c1\u306f\u4e2d\u83ef\u570f\u304a\u3088\u3073\u7c73\u56fd\u4ee5\u5916\u3067\u306e\u8ca9\u58f2\u3092\u62c5\u5f53\u3057\u307e\u3059\u3002<\/p>\n<p>IBI343\u306fCLDN18.2\u3092\u6a19\u7684\u3068\u3059\u308bADC\u3002\u73fe\u5728\u3001\u80c3\u304c\u3093\u304a\u3088\u3073\u80c3\u98df\u9053\u304c\u3093\u3092\u5bfe\u8c61\u306b\u7b2c3\u76f8\u8a66\u9a13\u3092\u5b9f\u65bd\u4e2d\u3002\u3053\u308c\u307e\u3067\u306e\u3068\u3053\u308d\u3001\u6709\u671b\u306a\u5b89\u5168\u6027\u3068\u6709\u52b9\u6027\u3092\u793a\u3057\u3066\u3044\u307e\u3059\u3002\u30a4\u30ce\u30d9\u30f3\u30c8\u306f\u6b66\u7530\u85ac\u54c1\u306b\u958b\u767a\u30fb\u88fd\u9020\u30fb\u8ca9\u58f2\u306b\u95a2\u3059\u308b\u72ec\u5360\u7684\u306a\u5168\u4e16\u754c\u3067\u306e\u6a29\u5229\u3092\u4ed8\u4e0e\u3057\u307e\u3059\u3002\u305f\u3060\u3057\u3001\u5927\u4e2d\u83ef\u570f\u306f\u9664\u304d\u307e\u3059\u3002\u4e21\u793e\u306f\u3001IBI343\u3092\u80c3\u764c\u304a\u3088\u3073\u81b5\u764c\u306e\u30d5\u30a1\u30fc\u30b9\u30c8\u30e9\u30a4\u30f3\u6cbb\u7642\u85ac\u3068\u3057\u3066\u4f7f\u7528\u3059\u308b\u3053\u3068\u3092\u76ee\u6307\u3057\u307e\u3059\u3002<\/p>\n<h4>\u3053\u3061\u3089\u3082\u304a\u8aad\u307f\u304f\u3060\u3055\u3044\uff1a <a class=\"p-url\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/a-d-a-m-partners-with-sophia-for-liquid-biopsy-japan\/\" rel=\"bookmark\">A.D.A.M.\u3001\u30ea\u30ad\u30c3\u30c9\u30d0\u30a4\u30aa\u30d7\u30b7\u30fc\u3067SOPHiA\u793e\u3068\u63d0\u643a<\/a><\/h4>\n<p>IBI3001\u306f\u3001EGFR\u3068B7-H3\u3092\u6a19\u7684\u3068\u3059\u308b\u30d5\u30a1\u30fc\u30b9\u30c8\u30fb\u30a4\u30f3\u30fb\u30af\u30e9\u30b9\u306e\u4e8c\u91cd\u7279\u7570\u6027ADC\u3067\u3042\u308a\u3001\u73fe\u5728\u3001\u81e8\u5e8a\u7b2c1\u76f8\u8a66\u9a13\u4e2d\u3067\u3059\u3002\u6b66\u7530\u85ac\u54c1\u306f\u3001\u5927\u4e2d\u83ef\u570f\u4ee5\u5916\u3067\u306e\u30b0\u30ed\u30fc\u30d0\u30eb\u3067\u306e\u72ec\u5360\u7684\u6a29\u5229\u3092\u53d6\u5f97\u3059\u308b\u3053\u3068\u3082\u53ef\u80fd\u3067\u3059\u3002\u305d\u306e\u5834\u5408\u3001\u958b\u767a\u3001\u88fd\u9020\u3001\u5546\u696d\u5316\u306e\u6a29\u5229\u304c\u542b\u307e\u308c\u307e\u3059\u3002<\/p>\n<p>\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u306e\u8ca1\u52d9\u69cb\u6210\u306f\u4ee5\u4e0b\u306e\u901a\u308a\u3002 <a href=\"https:\/\/www.takeda.com\/\">\u6b66\u7530\u00a0<\/a>\u3092\u30a4\u30ce\u30d9\u30f3\u30c8\u306b\u58f2\u5374\u3002\u3053\u308c\u306b\u306f\u3001\u30a4\u30ce\u30d9\u30f3\u30c8\u793e\u3078\u306e1\u5104US$\u306e\u682a\u5f0f\u6295\u8cc7\u304c\u542b\u307e\u308c\u307e\u3059\u3002\u30a4\u30ce\u30d9\u30f3\u30c8\u306f\u30013\u3064\u306e\u6cbb\u7642\u6cd5\u306e\u30de\u30a4\u30eb\u30b9\u30c8\u30fc\u30f3\u3068\u3057\u3066\u6700\u5927US$102\u5104\u30c9\u30eb\u3092\u53d7\u3051\u53d6\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002\u3053\u308c\u306b\u3088\u308a\u3001\u6f5c\u5728\u7684\u306a\u53d6\u5f15\u7dcf\u984d\u306f\u7d04US$114\u5104\u30c9\u30eb\u306b\u306a\u308a\u307e\u3059\u3002 <a href=\"https:\/\/www.innoventbio.com\/\">\u30a4\u30ce\u30d9\u30f3\u30c8\u30d0\u30a4\u30aa\u30ed\u30b8\u30af\u30b9<\/a> \u306f\u3001\u4e2d\u83ef\u570f\u4ee5\u5916\u3067\u3082\u5404\u6cbb\u7642\u85ac\u306e\u6bb5\u968e\u7684\u30ed\u30a4\u30e4\u30eb\u30c6\u30a3\u3092\u7372\u5f97\u3057\u307e\u3059\u3002\u7c73\u56fd\u3067\u306fIBI363\u306e\u5229\u76ca\u5206\u914d\u5951\u7d04\u304c\u3042\u308a\u307e\u3059\u3002<\/p>\n<p>\u3053\u306e\u63d0\u643a\u306f\u3001\u4e21\u793e\u304c\u30a4\u30ce\u30d9\u30f3\u30c8\u306eIO\u304a\u3088\u3073ADC\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u306e\u4e16\u754c\u7684\u306a\u666e\u53ca\u3092\u5f8c\u62bc\u3057\u3059\u308b\u3082\u306e\u3067\u3059\u3002\u3053\u306e\u63d0\u643a\u306f\u3001\u304c\u3093\u9818\u57df\u3067\u5927\u304d\u306a\u30cb\u30fc\u30ba\u3092\u62b1\u3048\u308b\u60a3\u8005\u3055\u3093\u306b\u65b0\u305f\u306a\u6cbb\u7642\u9078\u629e\u80a2\u3092\u3082\u305f\u3089\u3059\u3082\u306e\u3067\u3059\u3002\u307e\u305f\u3001\u4e16\u754c\u4e2d\u3067\u7cbe\u5bc6\u304c\u3093\u6cbb\u7642\u3092\u5411\u4e0a\u3055\u305b\u308b\u3068\u3044\u3046\u4e21\u793e\u306e\u30b3\u30df\u30c3\u30c8\u30e1\u30f3\u30c8\u3092\u5f8c\u62bc\u3057\u3057\u307e\u3059\u3002<\/p>","protected":false},"excerpt":{"rendered":"<p>Innovent Biologics and Takeda are teaming up. This global partnership seeks to accelerate the development and launch of Innovent\u2019s new immuno-oncology (IO) and antibody-drug conjugate (ADC) therapies. The partnership aims to provide groundbreaking cancer treatments to patients everywhere. It uses the combined skills of both companies. The collaboration highlights three main investigational therapies from Innovent\u2019s IO+ADC pipeline. IBI363 is a first-in-class bispecific antibody fusion protein that targets PD-1 and IL-2\u03b1. It shows strong anti-tumor effects. It&#8217;s a hopeful new therapy for immuno-oncology. IBI363 is now in global Phase 3 development. It targets second-line squamous non-small cell lung cancer (sqNSCLC). It has received Breakthrough Designation from China\u2019s NMPA and Fast Track [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":22760,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"wprm-recipe-roundup-name":"","wprm-recipe-roundup-description":"","postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""},"footnotes":""},"categories":[208,181,89,211,237,206],"tags":[8698,150,8699,8697,8700],"ppma_author":[572],"class_list":{"0":"post-22759","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-apac","8":"category-biotech","9":"category-health-tech","10":"category-japan","11":"category-news","12":"category-regional","13":"tag-adc-molecules","14":"tag-biotech","15":"tag-innovent-biologics","16":"tag-io-backbone-therapy","17":"tag-takeda"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Innovent and Takeda Join for Global IO Therapy Rollout<\/title>\n<meta name=\"description\" content=\"Innovent Biologics with Takeda to advance next-gen IO and ADC cancer therapies, aiming to deliver transformative treatments globally.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/innovent-biologics-teams-with-takeda-on-global-io-therapies\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Innovent and Takeda Join for Global IO Therapy Rollout\" \/>\n<meta property=\"og:description\" content=\"Innovent Biologics with Takeda to advance next-gen IO and ADC cancer therapies, aiming to deliver transformative treatments globally.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/innovent-biologics-teams-with-takeda-on-global-io-therapies\/\" \/>\n<meta property=\"og:site_name\" content=\"itbusinesstoday\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-22T12:19:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/10\/Innovent-Biologics-Announces-Global-Strategic-Partnership-with-Takeda-to-Bring-Innovents-Next-Gen-IO-Backbone-Therapy-and-ADC-Molecules-to-the-Global-Market.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"ITBT StaffWriter\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"ITBT StaffWriter\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u5206\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u30a4\u30ce\u30d9\u30f3\u30c8\u793e\u3068\u6b66\u7530\u85ac\u54c1\u304cIO\u7642\u6cd5\u306e\u30b0\u30ed\u30fc\u30d0\u30eb\u5c55\u958b\u3067\u63d0\u643a","description":"\u30a4\u30ce\u30d9\u30f3\u30c8\u30fb\u30d0\u30a4\u30aa\u30ed\u30b8\u30af\u30b9\u793e\u304c\u6b66\u7530\u85ac\u54c1\u3068\u6b21\u4e16\u4ee3IO\u304a\u3088\u3073ADC\u304c\u3093\u6cbb\u7642\u85ac\u306e\u958b\u767a\u3067\u63d0\u643a\u3001\u9769\u65b0\u7684\u306a\u6cbb\u7642\u3092\u30b0\u30ed\u30fc\u30d0\u30eb\u306b\u63d0\u4f9b\u3078.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/innovent-biologics-teams-with-takeda-on-global-io-therapies\/","og_locale":"ja_JP","og_type":"article","og_title":"Innovent and Takeda Join for Global IO Therapy Rollout","og_description":"Innovent Biologics with Takeda to advance next-gen IO and ADC cancer therapies, aiming to deliver transformative treatments globally.","og_url":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/innovent-biologics-teams-with-takeda-on-global-io-therapies\/","og_site_name":"itbusinesstoday","article_published_time":"2025-10-22T12:19:05+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/10\/Innovent-Biologics-Announces-Global-Strategic-Partnership-with-Takeda-to-Bring-Innovents-Next-Gen-IO-Backbone-Therapy-and-ADC-Molecules-to-the-Global-Market.webp","type":"image\/webp"}],"author":"ITBT StaffWriter","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"ITBT StaffWriter","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"2\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/innovent-biologics-teams-with-takeda-on-global-io-therapies\/#article","isPartOf":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/innovent-biologics-teams-with-takeda-on-global-io-therapies\/"},"author":{"name":"ITBT StaffWriter","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/94fb575e469aff25a4b938814d050f15"},"headline":"Innovent Biologics teams with Takeda on global IO therapies","datePublished":"2025-10-22T12:19:05+00:00","mainEntityOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/innovent-biologics-teams-with-takeda-on-global-io-therapies\/"},"wordCount":384,"publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/innovent-biologics-teams-with-takeda-on-global-io-therapies\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/10\/Innovent-Biologics-Announces-Global-Strategic-Partnership-with-Takeda-to-Bring-Innovents-Next-Gen-IO-Backbone-Therapy-and-ADC-Molecules-to-the-Global-Market.webp","keywords":["ADC Molecules","Biotech","Innovent Biologics","IO Backbone Therapy","Takeda"],"articleSection":["APAC","Biotech","Health Tech","Japan","News","Regional"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/innovent-biologics-teams-with-takeda-on-global-io-therapies\/","url":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/innovent-biologics-teams-with-takeda-on-global-io-therapies\/","name":"\u30a4\u30ce\u30d9\u30f3\u30c8\u793e\u3068\u6b66\u7530\u85ac\u54c1\u304cIO\u7642\u6cd5\u306e\u30b0\u30ed\u30fc\u30d0\u30eb\u5c55\u958b\u3067\u63d0\u643a","isPartOf":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website"},"primaryImageOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/innovent-biologics-teams-with-takeda-on-global-io-therapies\/#primaryimage"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/innovent-biologics-teams-with-takeda-on-global-io-therapies\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/10\/Innovent-Biologics-Announces-Global-Strategic-Partnership-with-Takeda-to-Bring-Innovents-Next-Gen-IO-Backbone-Therapy-and-ADC-Molecules-to-the-Global-Market.webp","datePublished":"2025-10-22T12:19:05+00:00","description":"\u30a4\u30ce\u30d9\u30f3\u30c8\u30fb\u30d0\u30a4\u30aa\u30ed\u30b8\u30af\u30b9\u793e\u304c\u6b66\u7530\u85ac\u54c1\u3068\u6b21\u4e16\u4ee3IO\u304a\u3088\u3073ADC\u304c\u3093\u6cbb\u7642\u85ac\u306e\u958b\u767a\u3067\u63d0\u643a\u3001\u9769\u65b0\u7684\u306a\u6cbb\u7642\u3092\u30b0\u30ed\u30fc\u30d0\u30eb\u306b\u63d0\u4f9b\u3078.","breadcrumb":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/innovent-biologics-teams-with-takeda-on-global-io-therapies\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/itbusinesstoday.com\/health-tech\/biotech\/innovent-biologics-teams-with-takeda-on-global-io-therapies\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/innovent-biologics-teams-with-takeda-on-global-io-therapies\/#primaryimage","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/10\/Innovent-Biologics-Announces-Global-Strategic-Partnership-with-Takeda-to-Bring-Innovents-Next-Gen-IO-Backbone-Therapy-and-ADC-Molecules-to-the-Global-Market.webp","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/10\/Innovent-Biologics-Announces-Global-Strategic-Partnership-with-Takeda-to-Bring-Innovents-Next-Gen-IO-Backbone-Therapy-and-ADC-Molecules-to-the-Global-Market.webp","width":1200,"height":800,"caption":"Innovent Biologics"},{"@type":"BreadcrumbList","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/innovent-biologics-teams-with-takeda-on-global-io-therapies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/itbusinesstoday.com\/"},{"@type":"ListItem","position":2,"name":"Innovent Biologics teams with Takeda on global IO therapies"}]},{"@type":"WebSite","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","description":"","publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","width":663,"height":275,"caption":"itbusinesstoday"},"image":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/94fb575e469aff25a4b938814d050f15","name":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png90b3cb23d1d9c08733d969d29ea2d30d","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","caption":"ITBT StaffWriter"},"description":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc\u306f\u3001IT Business Today\u306e\u793e\u5185\u5bc4\u7a3f\u8005\u3067\u3001\u30bf\u30a4\u30e0\u30ea\u30fc\u306a\u30cb\u30e5\u30fc\u30b9\u3068QuickBytes\u306e\u914d\u4fe1\u3092\u62c5\u5f53\u3057\u3066\u3044\u307e\u3059\u3002IT\u3001\u30cf\u30a4\u30c6\u30af\u3001\u4f01\u696d\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u6700\u65b0\u52d5\u5411\u3092\u30ab\u30d0\u30fc\u3057\u3001\u7c21\u6f54\u3067\u30a4\u30f3\u30d1\u30af\u30c8\u306e\u3042\u308b\u6700\u65b0\u60c5\u5831\u3092\u8aad\u8005\u306b\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002","sameAs":["https:\/\/itbusinesstoday.com\/"],"url":"https:\/\/itbusinesstoday.com\/ja\/author\/itbt-staffwriter\/"}]}},"authors":[{"term_id":572,"user_id":7,"is_guest":0,"slug":"itbt-staffwriter","display_name":"ITBT StaffWriter","avatar_url":{"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","url2x":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png"},"0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/22759","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/comments?post=22759"}],"version-history":[{"count":2,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/22759\/revisions"}],"predecessor-version":[{"id":22776,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/22759\/revisions\/22776"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media\/22760"}],"wp:attachment":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media?parent=22759"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/categories?post=22759"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/tags?post=22759"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/ppma_author?post=22759"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}